Citations

Showing 10 of 108104 citations.

Revision anatomic shoulder arthroplasty with posterior capsular plication for correction of posterior instability
Wanderman, Nathan , Assenmacher, Andrew T. , Sperling, John W. , Cofield, Robert H. , Alentorn-Geli, Eduard, Wanderman, Nathan R, Sanchez-Sotelo, Joaquin, Alentorn‐Geli, Eduard , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Orthopaedic Surgery | July 25, 2018 | Volume: 26 | Issue: 3 | Pages: No page available

10.1177/2309499018789527 | PMID 30041574 Get It

Background: Revision of failed anatomic total shoulder arthroplasty or hemiarthroplasty is a challenging procedure. Restoring adequate soft tissue balance in the revision setting can be particularly problematic. When persistent posterior instability is encountered in the revision setting, options include changing component position or size, posterior capsular plication (PCP), or conversion to a reverse arthroplasty. The purpose of this study was to report the clinical and radiographic outcomes, complications, and reoperations of PCP performed in the setting of revision anatomic shoulder arthroplasty. Patients and Methods: Between 1975 and 2013, 15 patients (16 shoulders) had PCP during revision anatomic shoulder arthroplasty. Indications for revision arthroplasty included posterior instability in 15, glenoid loosening in 3, polyethylene wear in 2, and glenoid erosion in 1 shoulder. The mean (standard deviation (SD)) age was 60.1 (12.6) years, and the median (range) follow-up was 68 (2–228) months. A retrospective chart review was conducted to obtain all data. Results: At the last follow-up, nine shoulders (56%) had absence of posterior radiographic subluxation. Five (31%) cases underwent reoperation due to persistent posterior instability. Complications were observed in seven (44%) cases. Complete pain relief was achieved in four (25%) shoulders. The mean (SD) postoperative forward flexion, external rotation, and the American Shoulder and Elbow Surgeons score were 110° (41°), 40° (29°), and 62.1 (21.9), respectively. Results were excellent in two (13%), satisfactory in seven (44%), and unsatisfactory in seven (44%) shoulders. Conclusions: PCP to correct posterior instability during revision anatomic shoulder arthroplasty had an unacceptably high failure rate. In these circumstances, consideration should instead be given to conversion to a reverse shoulder arthroplasty.
Case-based review: ependymomas in adults
Cachia, David , Lowe, Stephen , Andersen, Samuel, Olar, Adriana , Frankel, Bruce, Johnson, Derek R. , Kaufmann, Timothy J. , Cooper, Samuel Lewis , Gilbert, Mark R.

Mayo Clinic

Neuro-Oncology Practice | July 25, 2018 | Volume: 5 | Issue: 3 | Pages: 142-153

10.1093/nop/npy026 | PMID 31386035 Get It

Abstract Ependymomas are rare primary central nervous system (CNS) tumors in adults. They occur most commonly in the spinal cord, and have classically been graded histologically into World Health Organization (WHO) grades I, II, or III based on the level of anaplasia. Recent data are showing that genetic heterogeneity occurs within the same histological subgroup and that ependymomas arising from different CNS locations have different molecular signatures. This has renewed interest in developing targeting therapies based on molecular profiles especially given the variable outcomes with radiation and the poor results with cytotoxic agents. In this paper, we present the case of a 46-year-old woman with a classic presentation of spinal cord ependymoma and discuss the current histopathological and molecular classification for ependymomas as well as current guidelines for patient management.
Survey of modular ontology techniques and their applications in the biomedical domain
Pathak, Jyotishman , Johnson, Thomas M. , Chute, Christopher G.

Mayo Clinic

Integrated Computer-Aided Engineering | July 24, 2018 | Volume: 16 | Issue: 3 | Pages: 225-242

10.3233/ica-2009-0315 | PMID 21686030 Get It

“Whole Again”: Why Are Penile Transplants Less Controversial Than Uterine?
Allyse, Megan , Allyse, Megan A

Mayo Clinic

The American Journal of Bioethics | July 24, 2018 | Volume: 18 | Issue: 7 | Pages: 34-35

10.1080/15265161.2018.1478044 | PMID 30040581 Get It

Assessing Duty to Warn in Donated Embryos
Allyse, Megan , Rust, Laura, Allyse, Megan A

Mayo Clinic

The American Journal of Bioethics | July 24, 2018 | Volume: 18 | Issue: 7 | Pages: 75-76

10.1080/15265161.2018.1478038 | PMID 30040557 Get It

Distribution Of Indium-111 In Labeled Human Platelets: Implications In Platelet Survival And Dosimetry
Dewanjee, Mrinal K., Rao, Shyam A., Didisheim, Paul

Mayo Clinic

Thrombosis and Haemostasis | July 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1653279 Get It

Subcellular distribution of In-111 in In-111-labeled platelets (In-P1) determines the biodistribution and dosimetry of In-111 after the in vivo lysis of In-P1. Human platelets were labeled with In-111-oxine (In-Ox) and In- 111-troPolone (In-TPL) in ACD/saline (A/S) and plasma (P). In-P1 was lysed after 6 repeated freezing and thawing procedures. A fraction of In-P1-lysate (In-P1-LS) was filtered (0.22 ym) and passed through a calibrated Sephadex G-100 column for estimation of molecular weight (Mol. wt.) of In-bound Pl-protein. The In-P1-LS was injected in 15 rabbits and biodistribution (% I.D.) performed at 24 hours after I.V. administration. Results are tabulated below: 80 ± 11% and 70 ± 10% of In was bound to soluble platelet protein when platelets were labeled in plasma and A/S respectively. Mol. wt. of In-bound platelet protein was estimated as 52,000 ± 5,000 daltons. Biodistribution shows that In-PI-LS labeled in A/S localizes more in RES than plasma; whole body retention is also longer. These studies shed further light on the binding sites of In in platelets labeled in A/S or plasma media and their ultimate fate after administration
Following Mild Carotid Endothelial Injury, Platelet-Arterial Wall Interaction Is Impaired In Pigs With Von Willebrand'S Disease
Dewanjee, Mrinal K., Kaye, Michael P., Fass, David N., White, James G. , Bowie, E. J. Walter, Fuster, Valentı́n

Mayo Clinic

Thrombosis and Haemostasis | July 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1652579 Get It

Platelet-arterial wall interaction appears to be important in the genesis of atherosclerosis. Pigs with homozygous von Willebrand’s disease (vWd) appear resistant to atherosclerosis. We investigated whether there is impairment in platelet-arterial wall interaction in porcine vWd. Superficial endothelial injury was produced in a 4 cm segment of carotid artery by drying for 3 minutes in a stream of air which entered one end (100 ml/min) and exited through a small hole in the other end. This procedure was performed in 9 normal and 6 vWd pigs 24 hours after the I.V. infusion of III-Indium-labeled platelets. Carotid blood flow was re-established and the pigs were sacrificed 24 hours later and the carotids fixed in glutaraldehyde.The ratio of radioactivity (cpm/g) of injured/noninjured carotid arteries was markedly decreased in the vWd pigs. In addition, transmission and scanning electron microscopy confirmed superficial endothelial damage in all injured segments, but only significant platelet deposition in the normal pig injured segments.After a mild endothelial injury, this “in vivo” evidence of impaired platelet-arterial wall interaction in vWd may be related to the resistance to atherosclerosis in these animals.
Effect Of TicloPidine On Platelet Deposition In Gore-Tex And Autologous Vein Grafts
Murphy, K., Dewanjee, Mrinal K., Fuster, V., Didisheim, Paul, Kaye, Michael P.

Mayo Clinic

Thrombosis and Haemostasis | July 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1652494 Get It

To quantitatively study platelet deposition on arterial prostheses and the effect of platelet inhibitory therapy with ticlopidine, 14 dogs underwent bilateral femoral artery excision and replacement with one polytetrafluoroethylene (Gore-Tex) and one autologous vein graft. Five dogs received 60 mg/kg/day of ticlopidine orally on four consecutive days prior to surgery. Nine untreated dogs served as controls. Collagen-induced platelet aggregometry studies were performed at the end of day 4. Autologous indium-111-labeled platelets were injected 24 hours prior to surgery to serve as aplatelet marker. All animals received heparin (1 mg/kg I.V.) 5 minutes prior to excision of the arterial segment. Grafts were removed 1 hour following resumption of blood flow and gently flushed with 30 cc normal saline. Radioactivity per unit weight of Gore-Tex, vein and blood was determined with a gamma counter. The relative radioactivity with respect to the internal reference standard, blood, is tabulated below.Ticlopidine treated dogs showed a 15-fold reduction in platelet deposition on Gore-Tex grafts and a 3-fold reduction on venous grafts. Platelet deposition was reduced significantly in Gore-Tex grafts (P<0.001) to a level comparable to that in autologous veins. Platelet inhibitory effect was also observed in collagen-induced platelet aggregometry.According to this “in vivo” data, ticlopidine appears to be a promising platelet inhibiting agent.
Molecular Biology Of Factor Viii Coagulant Protein
Fass, David N., Knutson, Gaylord J.

Mayo Clinic

Thrombosis and Haemostasis | July 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1652428 Get It

Several laboratories report factor VIII coagulant (VIII: C) from human, bovine and porcine sources interact with Willebrand factor (WF). Bovine coagulant may be S-S bonded to WF: the human and porcine VIII:C may reversibly bind to WF. This interaction has been used by various laboratories to help purify the VIII:C. The VIII:C from all 3 species are activated by Ila and inactivated in EDTA. Our work has involved the porcine proteins bound by WF and anti-VIII:C antibodies. Human antibodies to human VIII:C bind porcine plasma proteins which on SDS-PAGE band at apparent MW 160K, 130K and 80K. These data are consistent with the human VIII:C (Switzer and McKee (JCI 60:819, 1977)). Their human material appears to contain S-S linked chains, porcine chains separate in SDS alone. Thrombin treatment results in loss of high molecular weight proteins and an appearance of activation/deactivation products at MW = 80K and 73K and lower. Two murine monoclonal anti-porcine VIII:C antibodies partially inactivate VIII:C while a third doesn’t. This latter antibody, when immobilized, removes activity from solutions of VIII:C dissociated from WF but not from solutions of undissociated VIII:C. The VIII:C immobilized through this antibody is still active, can be removed by organic solvent in active form, and contains the same protein chains as those bound to the polyclonal human anti- VIII:C. The monoclonal antibody VIII:C complex is inactivated and releases the 130K + 160K chains in EDTA. The 80K MW chain can be removed separately. Based on relative staining intensity in SDS gels, the porcine VIII:C at this stage of purity may be heterogeneous, (130K + 80K and 160K + 80K), with the chains associated through Ca++. The 80K MW chain, may bind the VIII:C to porcine WF. The site of this interaction does not seem to be critical to the measurement of VIII:C activity in vitro.
Generation Of Coagulation Factors By The Isolated Rat Liver Perfused With A Synthetic Blood Substitute
Owen, C. A. , Bowie, E. J. Walter

Mayo Clinic

Thrombosis and Haemostasis | July 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1652384 Get It

Measuring the release of small amounts of a clotting factor from an isolated perfused rat liver is difficult if the perfusate already contains some of the factor. Further, platelet-containing perfusates generate a coagulant activity that may invalidate clotting assays.We have successfully employed a completely synthetic blood substitute for rat liver perfusions. The perfusate is “Fluosol-43” generously furnished by Alpha Therapeutic Corporation. The oxygen-carrying perfluorochemical is FC-43 (perfluorotributylamine) and the substitute for albumin is hydroxyethyl starch. Using the Brauer perfusion technique, we found that rat livers in 5 hours released an average of 2.3% of the normal plasma concentration of prothrombin, 8.4% factor V, 16.2% factor VII, 7.0% factor IX, 3.7% factor X, 28.3% factor XI and 12.3% factor XII. Antithrombin III and plasminogen were also generated.Only minute amounts of factor VIII were released unless serum, cryoprecipitate or cryoprecipitate-free plasma was added; then the yield was 8.8% on average. The more “venom factor” (platelet aggregability with Bothrops alternata venom) added to the synthetic perfusate, the more factor VIII was released.